Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity

American Journal of Ophthalmology

Volumn 151, Issue 2, 2011, Pages

  Sato, Tatsuhiko ^a   Shima, Chiharu ^a   Kusaka, Shunji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BEVACIZUMAB;

ARTICLE; CLINICAL ARTICLE; CONGENITAL CATARACT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; VITRECTOMY; VITREOUS BODY;

EID: 78751646275     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.08.037     Document Type: Article

References (27)

1. T.L. Terry Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects Trans Am Ophthalmol Soc 40 1942 262 284
2. H. Mechoulam, and E.A. Pierce Retinopathy of prematurity: molecular pathology and therapeutic strategies Am J Pharmacogenomics 3 4 2003 261 277
3. K. Sonmez, K.A. Drenser, A. Capone Jr, and M.T. Trese vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity Ophthalmology 115 6 2008 1065 1070
4. T. Sato, S. Kusaka, H. Shimojo, and T. Fujikado Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity Ophthalmology 116 9 2009 1599 1603
5. T. Sato, S. Kusaka, H. Shimojo, and T. Fujikado Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity Ophthalmology 116 11 2009 2165 2169
6. H.A. Mintz-Hittner, and R.R. Kuffel Jr Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II Retina 28 6 2008 831 838
7. S. Kusaka, C. Shima, and K. Wada Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study Br J Ophthalmol 92 11 2008 1450 1455
8. G.Y. Koh, I. Kim, H.J. Kwak, M.J. Yun, and J.C. Leem Biomedical significance of endothelial cell specific growth factor, angiopoietin Exp Mol Med 34 1 2002 1 11
9. P.C. Maisonpierre, C. Suri, and P.F. Jones Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 5322 1997 55 60
10. C. Sundberg, M. Kowanetz, L.F. Brown, M. Detmar, and H.F. Dvorak Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo Lab Invest 82 4 2002 387 401
11. T.N. Sato, Y. Tozawa, and U. Deutsch Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Nature 376 6535 1995 70 74
12. S. Davis, T.H. Aldrich, and P.F. Jones Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning Cell 87 7 1996 1161 1169
13. C. Suri, P.F. Jones, and S. Patan Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 7 1996 1171 1180
14. J. Holash, S.J. Wiegand, and G.D. Yancopoulos New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF Oncogene 18 38 1999 5356 5362
15. J.T. Chi, H.Y. Chang, and G. Haraldsen Endothelial cell diversity revealed by global expression profiling Proc Natl Acad Sci U S A 100 19 2003 10623 10628
16. H. Takagi, S. Koyama, and H. Seike Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization Invest Ophthalmol Vis Sci 44 1 2003 393 402
17. T. Asahara, D. Chen, and T. Takahashi Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulated VEGF-induced postnatal neovascularization Circ Res 83 3 1998 233 240
18. H. Oh, H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda Hypoxia and vascular endothelial growth factor selectively up-regulated angiopoietin-2 in bovine microvascular endothelial cells J Biol Chem 274 22 1999 15732 15739
19. S.J. Mandriota, and M.S. Pepper Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia Circ Res 83 8 1998 852 859
20. International committee for the classification of retinopathy of prematurity The international classification of retinopathy of prematurity revisited Arch Ophthalmol 123 7 2005 991 999
21. H.V. Gimbel, and B.M. DeBroff Posterior capsulorhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery J Cataract Refract Surg 20 6 1994 658 664
22. G. Thurston, C. Suri, and K. Smith Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 286 5449 1999 2511 2514
23. G. Thurston, J.S. Rudge, and E. Ioffe Angiopoietin-1 protects the adult vasculature against plasma leakage Nat Med 6 4 2000 460 463
24. A.M. Joussen, V. Poulaki, and A. Tsujikawa Suppression of diabetic retinopathy with angiopoietin-1 Am J Pathol 160 5 2002 1683 1693
25. H.P. Hammes, J. Lin, and P. Wagner Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy Diabetes 53 4 2004 1104 1110
26. D. Watanabe, K. Suzuma, and I. Suzuma Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy Am J Ophthalmol 139 3 2005 476 481
27. T. Sato, S. Kusaka, N. Hashida, Y. Saishin, T. Fujikado, and Y. Tano Comprehensive gene expression profile in murine oxygen-induced retinopathy Br J Ophthalmol 93 1 2009 96 103